Immunic, Inc. (IMUX)
0.5337
+0.02
(+4.61%)
USD |
NASDAQ |
Dec 31, 16:00
0.5231
-0.01
(-1.99%)
After-Hours: 20:00
Immunic Market Cap: 64.20M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aardvark Therapeutics, Inc. | 285.77M |
| CEL-SCI Corp. | 15.96M |
| AIM ImmunoTech, Inc. | 0.8635M |
| IGC Pharma, Inc. | 26.13M |
| NovaBay Pharmaceuticals, Inc. | 710.70M |
Market Cap Related Metrics
| Price to Book Value | 6.114 |
| Price | 0.5337 |
| Earnings Yield | -162.2% |